Home » Stocks » NYXH

Nyxoah SA (NYXH)

Nyxoah will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Market Cap n/a
Revenue (ttm) 309,191
Net Income (ttm) -18.91M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Nyxoah SA has filed to go public with an IPO on the NASDAQ.

1 week ago - SEC

About NYXH

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, or OSA. Our lead solution is the Genio system, a CE-Marked, patient-centric, minimally invasive, next generation hypoglossal neurostimulation therapy for the treatment of moderate to severe OSA. Our innovative technology platform is a first-of-its-kind bilateral hypoglossal nerve stimulation device designed to treat OSA, by maintaining an open airway for a restful night’s sleep. We started generatin... [Read more...]

Industry
Medical Devices
IPO Date
Pending
CEO
Olivier Taelman
Employees
79
Stock Exchange
NASDAQ
Ticker Symbol
NYXH
Full Company Profile

Financial Performance

Financial numbers in millions EUR.
Financial Statements